Digene Granted FDA Approval for Rapid Capture System
Digene Corp was granted FDA approval for the Rapid Capture® System application that allows high-throughput testing with its Hybrid Capture® 2 (hc2) High-Risk HPV DNA Test™. Using the Rapid Capture System, 352 patient specimens can be processe
Read More